Antimicrobial resistance among gram-negative organisms in the intensive care unit

NM Clark, J Patterson, JP Lynch - Current opinion in critical care, 2003 - journals.lww.com
Antibiotic resistance continues to rise among hospital-acquired gram-negative pathogens.
Optimal management of these infections requires knowledge of local epidemiology and …

Treatment of Multidrug-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem …

J Garnacho-Montero, C Ortiz-Leyba… - Clinical Infectious …, 2003 - academic.oup.com
We prospectively evaluated the efficacy and toxicity of intravenously administered colistin in
35 episodes of ventilator-associated pneumonia (VAP) due to multidrug-resistant …

Infections due to Acinetobacter baumannii in the ICU

J Chastre - Seminars in respiratory and critical care medicine, 2003 - thieme-connect.com
Acinetobacter species are widespread environmental, nonfermentative, aerobic, gram-
negative coccobacilli. Most infections due to this organism are opportunistic in nature and …

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment

R Smolyakov, A Borer, K Riesenberg… - Journal of Hospital …, 2003 - Elsevier
The emergence of multidrug-resistant (MDR) Acinetobacter baumannii poses a therapeutic
problem. The aim of this study was to assess the risk factors for nosocomial MDR-A …

Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study

J Garnacho, J Sole-Violan, M Sa-Borges… - Critical care …, 2003 - journals.lww.com
Objective To determine whether ventilator-associated pneumonia caused by Acinetobacter
baumannii (VAPAB) is associated with increased mortality rate. Design A retrospective …

The epidemiology of multidrug-resistant Acinetobacter baumannii does the community represent a reservoir?

C Zeana, E Larson, J Sahni, SJ Bayuga… - Infection Control & …, 2003 - cambridge.org
Objective: To explore the role of the community as a potential reservoir for Acinetobacter
baumannii. Design: Antimicrobial resistance patterns and genotypes of A. baumannii …

Treatment of Acinetobacter spp. infections

AS Levin - Expert opinion on pharmacotherapy, 2003 - Taylor & Francis
Acinetobacter spp. are predominantly nosocomial pathogens of growing importance. One of
their important features is antimicrobial resistance that includes β-lactams, aminoglycosides …

Analysis of Prognostic Factors in 95 Patients with Acinetobacter baumannii Bacteremia

CH Chen, LC Lin, YJ Chang, CC Huang, CE Liu… - Infection, 2003 - Springer
Background: Because Acinetobacter baumannii bacteremia is a global problem, we were
motivated to characterize this disease in Taiwan. Patients and Methods: We analyzed …

Transverse myelitis associated with Acinetobacter baumanii intrathecal pump catheter-related infection

EE Ubogu, JR Lindenberg, MA Werz - Regional Anesthesia & Pain …, 2003 - rapm.bmj.com
Objective: To describe a late neurologic complication of intrathecal pump implantation and
show the methods used for the diagnosis and successful treatment of transverse myelitis in …

Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas

J Rodríguez-Baño, Á Pascual, J Gálvez… - … y microbiologia clinica, 2003 - Elsevier
Objetivo Análisis de la incidencia, características clínicas y pronóstico de las bacteriemias
por Acinetobacter baumannii Métodos Estudio prospectivo de la cohorte de bacteriemias …